Total Funding
59
69
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
70021
Intus Bio develops biotechnology solutions centered on microbiome analysis and diagnostic discovery.
- Paul Denslow: CEO & Co-founder
- Mark Driscoll: Co-founder & CSO
About the Company
Intus Bio utilizes its Titan-1 platform to combine long-read DNA sequencing with machine learning to identify bacterial strains and microbial functions. This technology supports the identification of biomarkers for the early detection and prevention of chronic conditions, including various forms of cancer. The company offers a gut health testing
service that provides individuals with data-driven insights into their internal microbial environment. Additionally, the firm collaborates with clinical and academic partners to apply its high-resolution data to drug development and precision therapeutics.
